Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448779) titled 'Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment' on Feb. 25.

Study Type: Observational

Primary Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia

Condition: AL Amyloidosis MGUS Multiple Myeloma Monoclonal Gammopathies

Recruitment Status: Recruiting

Date of First Enrollment: November 17, 2025

Target Sample Size: 100

Countries of Recruitment: Italy

To know more, visit https://clinicaltrials.gov/study/NCT07448779

Published by HT Digital Content Services with permission from Health Daily Digest....